3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Retinoblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Leukemia, Monocytic, Acute
1
Leukemia
1
Hodgkin Disease
1
Hepatoblastoma
1
Febrile Neutropenia
1
Fallopian Tube Neoplasms
1
Chemotherapy-induced Neutropenia
1
Chemotherapy-Induced Febrile Neutropenia
1
Breast Neoplasms
1
Interventions
Meropenem
2
pegfilgrastim
1
Vancomycin
1
TKN732
1
Simvastatin
1
Piperacillin, Tazobactam Drug Combination
1
Magnetic Resonance Myelography
1
Levofloxacin
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Ceftazidime
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Febrile Neutropenia
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT02427919
2015-04-28
DeGREE
Seoul St. Mary's Hospital
Phase 2/3
Unknown
56 enrolled